Safety and efficacy of once-daily nevirapine dosing: a multicohort studyCALMY, Alexandra; VALLIER, Nathalie; YIP, Benita et al.Antiviral therapy (London). 2009, Vol 14, Num 7, pp 931-938, issn 1359-6535, 8 p.Article

Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapyKESSELRING, Anouk M; WIT, Ferdinand W; MOCROFT, Amanda et al.AIDS (London). 2009, Vol 23, Num 13, pp 1689-1699, issn 0269-9370, 11 p.Article

Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapyCASULA, Miriam; WEVERLING, Gerrit Jan; WIT, Ferdinand W et al.The Journal of infectious diseases. 2005, Vol 192, Num 10, pp 1794-1800, issn 0022-1899, 7 p.Article

Virologic and immunologic response to highly active antiretroviral therapy in indigenous and nonindigenous HIV-1-infected patients in The NetherlandsNELLEN, Jeannine F; WIT, Ferdinand W; DE WOLF, Frank et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 4, pp 943-950, issn 1525-4135, 8 p.Article

Semen quality remains stable during 96 weeks of untreated human immunodeficiency virus-1 infectionVAN LEEUWEN, Elisabeth; WIT, Ferdinand W; PRINS, Jan M et al.Fertility and sterility. 2008, Vol 90, Num 3, pp 636-641, issn 0015-0282, 6 p.Article

Low risk of treatment failure after substitution of nevirapine for protease inhibitors among human immunodeficiency virus-infected patients with virus suppressionDIELEMAN, Jeanne P; STURKENBOOM, Miriam C. J. M; WIT, Ferdinand W et al.The Journal of infectious diseases. 2002, Vol 185, Num 9, pp 1261-1268, issn 0022-1899Article

Safe interruption of Maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapyKIRK, Ole; REISS, Peter; UBERTI-FOPPA, Caterina et al.Annals of internal medicine. 2002, Vol 137, Num 4, pp 239-250, issn 0003-4819Article

Adherence to HIV Therapeutic Drug Monitoring Guidelines in The NetherlandsVAN LUIN, Matthijs; WIT, Ferdinand W; SMIT, Colette et al.Therapeutic drug monitoring. 2011, Vol 33, Num 1, pp 32-39, issn 0163-4356, 8 p.Article

Efavirenz Dose Reduction Is Safe in Patients With High Plasma Concentrations and May Prevent Efavirenz DiscontinuationsVAN LUIN, Matthijs; GRAS, Luuk; RICHTER, Clemens et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 240-245, issn 1525-4135, 6 p.Conference Paper

Mitochondrial DNA decline in T cells of HIV-1 seroconverters may be dependent on immune activationCASULA, Miriam; VRISEKOOP, Nienke; WIT, Ferdinand W et al.The Journal of infectious diseases. 2007, Vol 196, Num 3, pp 371-376, issn 0022-1899, 6 p.Article

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort studyHAMERS, Raph L; SCHUURMAN, Rob; OSIBOGUN, Akin et al.Lancet. Infectious diseases (print). 2012, Vol 12, Num 4, pp 307-317, issn 1473-3099, 11 p.Article

Immune restoration and onset of new AIDS-defining events with combination antiretroviral therapy in HIV type-1-infected immigrants in the NetherlandsKESSELRING, Anouk M; GRAS, Luuk; WIT, Ferdinand W et al.Antiviral therapy (London). 2010, Vol 15, Num 6, pp 871-879, issn 1359-6535, 9 p.Article

Lower atovaquone/proguanil concentrations in patients taking efavirenz, lopinavir/ritonavir or atazanavir/ritonavirVAN LUIN, Matthijs; VAN DER ENDE, Marchina E; KUKS, Paul F. M et al.AIDS (London). 2010, Vol 24, Num 8, pp 1223-1226, issn 0269-9370, 4 p.Article

Effects of antiretroviral therapy on semen quality. CommentaryVAN LEEUWEN, Elisabeth; WIT, Ferdinand W; REPPING, Sjoerd et al.AIDS (London). 2008, Vol 22, Num 5, issn 0269-9370, 637-642, 647-648 [8 p.]Article

Quality of life in patients treated with first-line antiretroviral therapy containing nevirapine and/or efavirenzVAN LETH, Frank; CONWAY, Brian; LAPLUME, Hector et al.Antiviral therapy (London). 2004, Vol 9, Num 5, pp 721-728, issn 1359-6535, 8 p.Article

Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGE_hIV Cohort StudySCHOUTEN, Judith; WIT, Ferdinand W; STOLTE, Ineke G et al.Clinical infectious diseases. 2014, Vol 59, Num 12, pp 1787-1797, issn 1058-4838, 11 p.Article

Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE StudyCOTTER, Aoife G; VROUENRAETS, Saskia M. E; BRADY, Jennifer J et al.The Journal of clinical endocrinology and metabolism. 2013, Vol 98, Num 4, pp 1659-1666, issn 0021-972X, 8 p.Article

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational studyHAMERS, Raph L; WALLIS, Carole L; NANKYA, Immaculate et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 750-759, issn 1473-3099, 10 p.Article

Increased carotid intima-media thickness in HIV patients treated with protease inhibitors as compared to non-nucleoside reverse transcriptase inhibitorsSANKATSING, Raaj R; WIT, Ferdinand W; VOGEL, Martin et al.Atherosclerosis. 2009, Vol 202, Num 2, pp 589-595, issn 0021-9150, 7 p.Article

Effects of nevirapine, compared with lamivudine, on lipids and lipoproteins in HIV-1-uninfected newborns : The stopping infection from mother-to-child via breast-feeding in africa lipid substudySANKATSING, Raaj R; WIT, Ferdinand W; PAKKER, Nadine et al.The Journal of infectious diseases. 2007, Vol 196, Num 1, pp 15-22, issn 0022-1899, 8 p.Article

CC chemokine receptor 5 Δ32 and CC chemokine receptor 2 641 polymorphisms do not influence the virologic and immunologic response to antiretroviral combination therapy in human immunodeficiency virus type 1-infected patientsWIT, Ferdinand W. N. M; VAN RIJ, Ronald P; WEVERLING, Gerrit Jan et al.The Journal of infectious diseases. 2002, Vol 186, Num 12, pp 1726-1732, issn 0022-1899, 7 p.Article

Discordant responses during antiretroviral therapy: role of immune activation and T cell redistribution rather than true CD4 T cell lossHAZENBERG, Mette D; OTTO, Sigrid A; WIT, Ferdinand W. N. M et al.AIDS (London). 2002, Vol 16, Num 9, pp 1287-1289, issn 0269-9370Article

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapyWIT, Ferdinand W. N. M; WEVERLING, Gerrit Jan; WEEL, Jan et al.The Journal of infectious diseases. 2002, Vol 186, Num 1, pp 23-31, issn 0022-1899Article

Low Bone Mineral Density, Regardless of HIV Status, in Men Who Have Sex With MenGRIJSEN, Marlous L; VROUENRAETS, Saskia M. E; WIT, Ferdinand W. N. M et al.The Journal of infectious diseases. 2013, Vol 207, Num 3, pp 386-391, issn 0022-1899, 6 p.Article

A phase I/IIa study with succinylated human serum albumin (Suc-HSA), a candidate HIV-1 fusion inhibitorVERMEULEN, Joost N; MEIJER, Dirk K. F; OVER, Jan et al.Antiviral therapy (London). 2007, Vol 12, Num 2, pp 273-278, issn 1359-6535, 6 p.Article